SSH - TULSA / MIDTOWN LLC — History
CCN 372007 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$18M
Latest Revenue (FY2022)
+11.9%
Revenue CAGR (3yr)
-6.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | — | $18M | +nan% | +11.9% |
| Operating Expenses | $16M | $20M | $20M | -3.2% | +10.2% |
| Operating Margin | -9.8% | 0.0% | -6.4% | — | +0.0% |
| Net Income | $-1M | $-20M | $-1M | +94.1% | +0.0% |
| Licensed Beds | 50 | 46 | 46 | +0.0% | -4.1% |
| Total Patient Days | 8,724 | 8,610 | 8,952 | +4.0% | +1.3% |
| Medicare Day % | 48% | 54% | 49% | -9.7% | +1.0% |
| Medicaid Day % | 6% | 5% | 5% | +19.9% | -4.5% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +25.2% ($15M → $18M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.9%
This Hospital
+7.6%
State Avg
Latest Margin
-6.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | — | -3.1% |
| FY2024 (proj) | — | 0.3% |
| FY2025 (proj) | — | 3.6% |